Nicotin Al (Nicotine)

Nicotine, the active ingredient in Nicotin Al, is a nicotinic agonist presented as an oral formulation for oral use. It treats smoking cessation in adults who are trying to quit tobacco.\n\nGNH India supplies Nicotin Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nicotin Al is a nicotinic agonist indicated for conditions related to tobacco dependence.\n\n- Smoking cessation: Helps reduce withdrawal symptoms and cravings during quit attempts.\n- Nicotine dependence: Supports adult smokers in managing dependence on nicotine.\n- Tobacco use disorder: Assists in controlling cravings and improving quit rates in individuals attempting to stop smoking.

Nicotin Al may cause a range of adverse reactions, which are categorized by frequency and severity.\n\nCommon Side Effects:\n- Nausea\n- Headache\n- Dizziness\n- Insomnia\n- Irritability\n- Mouth irritation\n\nSerious or Rare Side Effects:\n- Cardiovascular events (e.g., hypertension, arrhythmia)\n- Severe allergic reaction (anaphylaxis)\n- Seizures\n- Respiratory depression\n- Hypotension\n- Persistent vomiting

When prescribing Nicotin Al, clinicians should consider several safety aspects.\n\n- Assess cardiovascular status: evaluate history of heart disease before initiation.\n- Monitor glucose control: nicotine may affect blood sugar levels in diabetic patients.\n- Review psychiatric history: nicotine can influence mood and anxiety.\n- Caution in pregnancy and lactation: safety data are limited; use only if benefits outweigh risks.\n- Avoid use in patients with known hypersensitivity to nicotine.\n- Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Nicotin Al can interact with other medicines, requiring attention to avoid adverse outcomes.\n\nMajor Interactions (Avoid):\n- Monoamine oxidase inhibitors (MAOIs): may increase hypertensive response.\n- CYP2A6 inhibitors: can alter nicotine metabolism and increase exposure.\n- Insulin: nicotine may affect glucose regulation, requiring dose adjustments.\n\nModerate Interactions (Monitor Closely):\n- Antidepressants (SSRIs): may increase nausea when combined.\n- Antihypertensive agents: nicotine can reduce their efficacy.\n- Oral contraceptives: nicotine may decrease hormonal effectiveness.